301786
Implementing Universal Pulse Oximetry Screening in Newborns through the West Virginia Birth Score Program
Methods: All WV birth hospitals were provided with the U.S. Department of Health and Human Services recommendations, and the Center for Disease Control’s recommended screening algorithm for review and reference. 21,115 infants received a Birth Score between September 1, 2012 and August 31, 2013. 19,283 (91.3%) infants were eligible for the pulse ox screening.
Results: 17,101 (88.5%) infants passed, 19 infants failed, and 2,163 (11.2%) infants had missing data for the screening. 832 infants were not screened due to being admitted to the neonatal intensive care unit for reasons unknown. 17 infants had transthoracic echo reports available for review, of which seven were diagnosed with CCHD.
Conclusions: 88.8% of the infants who received a Birth Score during the year reviewed were confirmed as being screened. Given that the goal is to have 100% compliance with the pulse oximetry screening, additional investigations into factors affecting compliance may be necessary.
Learning Areas:
EpidemiologyProgram planning
Public health or related laws, regulations, standards, or guidelines
Public health or related research
Learning Objectives:
Describe how pulse oximetry screening was implemented for all newborns in West Virginia.
Discuss the challenges of 100% compliance with pulse oximetry screening and data collection in West Virginia birth hospitals.
Demonstrate understanding of the challenges associated with new state mandates and policy implementations at the hospital level.
Keyword(s): Screening Instruments, Public Health Policy
Qualified on the content I am responsible for because: I am a clinical professor of Pediatrics and have been the Principal Investigator and Medical Director for the WV Birth Score Program state funded grant since 2012.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.